School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Sight Sciences, Inc. SGHT

Healthcare · Medical Devices

$8.97last close 2026-10-12 · market cap $493.86M · delayed data

Trailing returns

1M+10.14%
3M+68.52%
6M+159.86%
1Y+180.16%
5Y-60.26%

Basis: Adjusted daily closes.

What it does

Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the United States. The company operates in two segments, Surgical Glaucoma and Dry Eye.

Open SGHT in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies